A possible mechanistic explanation for the paradox that CD109 loss promotes EMT, but forfeits tumorigenicity and metastatic ability in SCC cells is that the loss of CD109 action leads to an irreversible and tumor-suppressive EMT program which generates fully differentiated mesenchymal phenotype (110). Here, CD109 is linked to neoplasm.